Industry practice has changed radically over the past five decades. Can laws published in the 1960s still ensure pharmaceutical quality and safety today?
The biopharmaceutical industry has undergone major changes since GMPs were last updated in 1977. However, FDA says it has no plans for any major revisions of cGMPs. Industry experts argue, however, that changes are needed in Training and employee personal development, statistics and sampling, and process validation.
Read this article in BioPharm International’s September 2019 Regulatory Sourcebook.
BioPharm International
eBook: Regulatory Sourcebook, September 2019
September 2019
Pages: 10–13
When referring to this article, please cite it as A. Shanley, “Is it Time to Update cGMPs?" BioPharm International Regulatory Sourcebook eBook (September 2019).
Guidance on Quality Culture Standards
June 3rd 2025Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.